http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008504302-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C53-134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2005-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008504302-A
titleOfInvention Atomoxetine and tomoxetine mandelate pure with respect to enantiomers
abstract The present invention provides (R)-(−)-tomoxetine (S)-(+)-mandelate and atomoxetine HCl pure with respect to enantiomers. The present invention further provides enantiomerically pure (R)-(−)-tomoxetine (S)-(+)-mandelate prepared from racemic tomoxetine. The present invention also provides atomoxetine HCl pure from the enantiomer prepared from (R)-(−)-tomoxetine (S)-(+)-mandelate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008516002-A
priorityDate 2004-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H037250-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3027979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420309845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426096936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450697937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4398339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416223349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439616

Total number of triples: 58.